• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,944.90
    417.55 (+0.75%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Samrat Pharmachem Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4878.0
  • ISIN : INE103E01016
348.20 7 (2.02%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    331.00

  • Today’s High

    350.20

  • Open

    331.00

  • Perv Close

    341.30

  • 52W Low

    302.05

  • 52W High

    646.00

Key Indicators

  • P/E(TTM)

    15.13

  • Mar.Cap (₹Cr.)

    107.58

  • Div & Yield %

    0.29

  • Book Value(₹)

    232.38

  • Debt-Equity Ratio

    2.02

  • AGM Date

    16-Jun-2025

  • EPS

    23.02

  • P/E Ratio

    15.13

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    107.58

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.09

  • BV (₹)

    232.40

  • Sales( ₹ in Cr.)

    285.86

  • NP (in Cr.)

    7.11

  • NP Var(%)

    231.0

  • Div%

    10.0

  • CPS (₹)

    25.10

  • EPS (₹)

    23.00

  • Traded Value (₹ in Lakhs)

    107.58

  • 52 Week High

    646.00

  • 52 Week Low

    302.05

  • Price BSE

    348.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    107.58

  • P/C Ratio

    13.80

  • P/E Ratio

    15.10

  • Price Vs.BV

    23.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 281.58 310.65 221.75 204.37 157.12 125.36
Excise Duty 0.00 0.00 0.00 25.35 19.66 14.22
Net Sales 281.58 310.65 221.75 179.02 137.46 111.14
Other Income 1.38 0.48 0.63 0.46 0.57 0.46
Stock Adjustments -4.84 10.14 0.33 -2.23 6.18 0.91
Total Income 278.12 321.27 222.71 177.25 144.21 112.51
EXPENDITURE :            
Raw Materials 265.48 288.00 190.23 162.02 131.80 103.53
Power and Fuel Cost 1.37 1.46 1.34 1.12 0.91 0.73
Employee Cost 1.11 1.07 0.96 1.05 1.00 0.94
Other Manufacturing Expenses 2.17 2.47 2.29 1.65 1.34 1.52
Selling and Administration Expenses 3.36 3.10 2.46 1.83 1.83 2.09
Miscellaneous Expenses 0.78 0.76 0.55 0.47 0.13 0.05
Employee Benefit Expenses 1.11 1.07 0.96 1.05 1.00 0.94
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 274.27 296.85 197.84 168.14 137.02 108.87
Operating Profit 3.86 24.40 24.87 9.12 7.19 3.64
Interest 0.69 1.23 0.67 1.28 0.98 1.06
Gross Profit 3.17 23.17 24.20 7.84 6.21 2.58
Depreciation 0.65 0.64 0.59 0.49 0.43 0.42
Profit Before Tax 2.52 22.53 23.61 7.35 5.78 2.16
Current Tax 0.28 6.11 6.39 1.72 1.73 0.61
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.08 -0.21 0.03 0.29 -0.18 0.01
Reported Net Profit 2.16 16.63 17.18 5.33 4.24 1.54
Extraordinary Items 0.02 0.00 -0.02 -0.01 -0.01 0.00
Adjusted Net Profit 2.14 16.63 17.20 5.34 4.25 1.54
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 60.05 43.73 26.55 21.21 16.98 15.44
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.31 0.31 0.00 0.00 0.00 0.00
P & L Balance carried down 61.91 60.05 43.73 26.55 21.21 16.98
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 0.00 0.00 0.00
Dividend Per Share(Rs) 1.00 1.00 1.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.00 53.83 55.62 17.26 13.71 4.97
Earnings Per Share(Adj)-Unit Curr 7.00 53.83 55.62 17.26 13.71 4.97
Book Value 210.37 204.37 151.54 95.92 78.66 64.95
Book Value(Adj)-Unit Curr 210.37 204.37 151.54 95.92 78.66 64.95

Shareholding Pattern

  • Promoter Group

    49.09%

  • Public Share Holding

    50.91%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,516,767 49.09 1,516,767 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,516,767 49.09 1,516,767 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 100,000 3.24 0 1
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 100,000 3.24 0 1
2] Non Institution
Bodies Corporate 80,155 2.59 78,655 35
Clearing Members 96 0.00 96 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 60,568 1.96 50,168 129
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 45,963 1.49 45,963 105
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 173,757 5.62 173,757 3
Individuals holding nominal share capital up to Rs. 1 lakh 1,111,022 35.96 912,622 6,497
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 572 0.02 572 2
Sub Total 1,472,933 47.67 1,262,333 6,774
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,089,700 100.00 2,779,100 6,785

Company Background

Samrat Pharmachem LtdPharmaceuticals - Indian - Bulk Drugs

  • Samrat Pharmachem Ltd
  • BSE Code : 4878.0
  • ISIN : INE103E01016

  • Incorporation Year

    1992

  • Registered Office

    Plot No A2/3445
    GIDC Phase IV, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-2646-220774

  • FAX

    91-2646-251291

  • Chairman

    Lalit Mehta

  • Managing Director

    Lalit Mehta

  • Company Secretary

    Nishant Kankaria

  • Auditor

    Shah & Savla LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    C-13 Pannalal Silk,
    Mills Cmpd LBS Marg,Bhandup West
    Mumbai - Mumbai - 400 078

Samrat Pharmachem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Samrat Pharma 348.20 282.97 281.58 15.13 4.14
Abbott India 31,658.15 6,097.18 5,848.91 47.56 44.71
Astrazeneca Phar 10,204.20 1,330.33 1,295.53 220.39 33.26
P & G Health Ltd 5,907.60 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,366.50 3,866.05 3,723.49 62.06 58.72
Cipla 1,526.90 17,645.00 16,574.34 23.91 20.10
Amrutanjan Healt 700.10 437.58 421.23 39.82 20.84
Guj. Themis Bio. 349.55 174.19 169.82 78.02 44.82
Fermenta Biotec. 341.00 315.24 307.09 14.85 4.10
Bliss GVS Pharma 147.30 638.96 605.46 22.49 11.19
Ambalal Sarabhai 36.91 11.70 3.81 34.18 1.92